Vasculitis Activity-Predicting Ability of IL-12 Family Cytokines in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The present study investigated and compared the antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) activity-predicting ability of the serum concentrations of the four interleukin (IL)-12 family cytokines including IL-23, IL 27, IL-35, and IL-39 in patients with microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA). Materials and Methods: The present study included 70 patients with MPA and GPA. Clinical and laboratory data, particularly Bir mingham Vasculitis Activity Score (BVAS), at the time of blood collection were obtained. The serum concentrations of IL-23, IL-27, IL-35, and IL-37 were measured using sera stored at -80°C. Patients were divided into two groups: the upper half of BVAS (BVAS ≥12) and the lower half of BVAS (BVAS <12). Results: The serum concentrations of IL-23 and IL-27 reflected AAV activity. Patients with the upper half of BVAS exhibited signifi cantly higher serum concentrations of IL-23 and IL-27 than those without. Patients with the serum concentrations of IL-23 ≥132.1 pg/mL or IL-27 ≥684.7 pg/mL exhibited higher frequency and risk for the upper half of BVAS than those without [relative risks (RR)5.143 and RR 4.091, respectively]. The serum concentrations of IL-27 were associated with age ≥65 years and proteinase 3-ANCA (or C-ANCA) negativity, whereas, those of IL-23 were associated with MPA. However, the serum concentrations of IL-35 and IL-39 were not useful in predicting AAV activity in this study. Conclusion: The present study is the first to demonstrate that among the various members of IL-12 family cytokines, the serum concentrations of IL-23 and IL-27 possess AAV activity-predicting ability.
Abstract
Purpose: The present study investigated and compared the antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) activity-predicting ability of the serum concentrations of the four interleukin (IL)-12 family cytokines including IL-23, IL 27, IL-35, and IL-39 in patients with microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA). Materials and Methods: The present study included 70 patients with MPA and GPA. Clinical and laboratory data, particularly Bir mingham Vasculitis Activity Score (BVAS), at the time of blood collection were obtained. The serum concentrations of IL-23, IL-27, IL-35, and IL-37 were measured using sera stored at -80°C. Patients were divided into two groups: the upper half of BVAS (BVAS ≥12) and the lower half of BVAS (BVAS <12). Results: The serum concentrations of IL-23 and IL-27 reflected AAV activity. Patients with the upper half of BVAS exhibited signifi cantly higher serum concentrations of IL-23 and IL-27 than those without. Patients with the serum concentrations of IL-23 ≥132.1 pg/mL or IL-27 ≥684.7 pg/mL exhibited higher frequency and risk for the upper half of BVAS than those without [relative risks (RR)5.143 and RR 4.091, respectively]. The serum concentrations of IL-27 were associated with age ≥65 years and proteinase 3-ANCA (or C-ANCA) negativity, whereas, those of IL-23 were associated with MPA. However, the serum concentrations of IL-35 and IL-39 were not useful in predicting AAV activity in this study. Conclusion: The present study is the first to demonstrate that among the various members of IL-12 family cytokines, the serum concentrations of IL-23 and IL-27 possess AAV activity-predicting ability.
참고문헌 (31)
- Mirlekar B, "IL-12 family cytokines in cancer and immunotherapy", Cancers(Basel), 13, pp.167~ (2021)
- Wang X, "The IL-12 family cytokines in fish : molecular structure, expression profile and function", Dev Comp Immunol, 141, pp.104643~ (2023)
- Belladonna ML, "Bioengineering heterodimeric cytokines : turning promiscuous proteins into therapeutic agents", Biotechnol Genet Eng Rev, 29, pp.149~174 (2013)
- Sawant DV, "Interleukin-35 : expanding its job profile", J Interferon Cytokine Res, 35, pp.499~512 (2015)
- Lu Z, "Interleukin 39 : a new member of interleukin 12 family", Cent Eur J Immunol, 45, pp.214~217 (2020)
- Yayla ME, "E, Yurteri EU, Küçüks¸ahin O, Dinçer ABK, et al. Serum interleukin 35 levels in systemic sclerosis and relationship with clinical features", J Clin Rheumatol, 26, pp.83~86 (2020)
- Pope RM, "Possible roles of IL-12-family cytokines in rheumatoid arthritis", Nat Rev Rheumatol, 9, pp.252~256 (2013)
- He D, "Interleukin-35 as a new biomarker of renal involvement in lupus nephritis patients", Tohoku J Exp Med, 244, pp.263~270 (2018)
- Kang BY, "Targeting cytokines of the interleukin-12 family in autoimmunity", Curr Med Chem, 13, pp.1149~1156 (2006)
- Watts R, "Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies", Ann Rheum Dis, 66, pp.222~227 (2007)
- Jennette JC, "2012 revised international Chapel Hill Consensus Conference nomenclature of vasculitides", Arthritis Rheum, 65, pp.1~11 (2013)
- 최찬범, "Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review", Yonsei Medical Journal, 60(1), pp.10~21 (2019), 연세대학교의과대학[DOI]
- Kitching AR, "ANCA-associated vasculitis", Nat Rev Dis Primers, 6, pp.71~ (2020)
- Nogueira E, "Serum IL-17 and IL-23 levels and autoantigenspecific Th17 cells are elevated in patients with ANCA-associated vasculitis", Nephrol Dial Transplant, 25, pp.2209~2217 (2010)
- Yoon T, "Predictive ability of serum IL-27 level for assessing activity of antineutrophil cytoplasmic antibody-associated vasculitis", Mediators Inflamm, 2021, pp.6668884~ (2021)
- Suppiah R, "2022 American College of Rheumatology", European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis, 2022, pp.81, 321~326
- Robson JC, "2022 American College of Rheumatology", European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis, 2022, pp.81, 315~320
- 표정윤, "Comparison of the 2022 ACR", EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria, 2023, pp.64(1), 11~17[DOI]
- Bossuyt X, "Position paper : revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis", Nat Rev Rheumatol, 13, pp.683~692 (2017)
- McAdoo SP, "Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis", Nephrol Dial Transplant, 34, pp.63~73 (2019)
- Mukhtyar C, "Modification and validation of the Birmingham Vasculitis Activity Score(version 3)", Ann Rheum Dis, 68, pp.1827~1832 (2009)
- Guillevin L, "The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort", Medicine(Baltimore), 90, pp.19~27 (2011)
- Han CW, "Development of the Korean version of short-form 36-item health survey : health related QOL of healthy elderly people and elderly patients in Korea", Tohoku J Exp Med, 203, pp.189~194 (2004)
- Bhamra K, "Damage assessment in ANCA-associated vasculitis", Curr Rheumatol Rep, 14, pp.494~500 (2012)
- Abdalla AE, "Biology of IL-27 and its role in the host immunity against Mycobacterium tuberculosis", Int J Biol Sci, 11, pp.168~175 (2015)
- Schinocca C, "Role of the IL-23", IL-17 pathway in rheumatic diseases : an overview, 2021, pp.12, 637829~
- Hasegawa H, "Expanding diversity in molecular structures and functions of the IL-6", IL-12 heterodimeric cytokine family, 2016, pp.7, 479~
- Hunter CA, "New IL-12-family members : IL-23 and IL-27, cytokines with divergent functions", Nat Rev Immunol, 5, pp.521~531 (2005)
- Zeitvogel J, "IL-27 acts as a priming signal for IL-23 but not IL-12 production on human antigen-presenting cells", Exp Dermatol, 21, pp.426~430 (2012)
- Xie Y, "Interleukin-35 in autoimmune dermatoses: current concepts", Open Med(Wars), 17, pp.589~600 (2022)
- Lai X, "Circulating IL-27 is elevated in rheumatoid arthritis patients", Molecules, 21, pp.1565~ (2016)